MarketBeat provided stock performance data and analyst recommendations for Regeneron Pharmaceuticals and IDEAYA Biosciences.
2 reports, 1 independent
Updated Sep 15
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat provided stock performance data and analyst recommendations for Regeneron Pharmaceuticals and IDEAYA Biosciences.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Regeneron Pharmaceuticals
American pharmaceutical company
-
MarketBeat
American personal finance blog
Related events
- MarketBeat reported on the stock performance of Allarity Therapeutics, Inc. on September 1, 2026.
- MarketBeat compared the financial performance and risk profiles of various financial stocks, including Business First Bancshares.
- MarketBeat reported on the financial performance of Donnelley Financial Solutions.
- MarketBeat is reporting on the financial performance of two mid-cap technology companies, Oxford Instruments and Standex International.
- MarketBeat provided analyst ratings and recommendations for Tempo Automation Holdings, Inc. and Key Tronic Corp.